Evidence map›Paper›PMID 21161531›Full record

ArticleRheumatology international2012

Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2.

B Kloesch, M Liszt, G Steiner, J Bröll

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. HBiomolecules · 2021
    Review
  4. The Gasotransmitter Hydrogen Sulfide (HAntioxidants (Basel, Switzerland) · 2021
    Article
  5. Article
  6. Trends in HAntioxidants (Basel, Switzerland) · 2021
    Review
  7. Hydrogen Sulfide and the Immune System.Advances in experimental medicine and biology · 2021
    Article
  8. Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis.Advances in experimental medicine and biology · 2021
    Review
  9. Hydrogen Sulfide: a Novel Immunoinflammatory Regulator in Rheumatoid Arthritis.Advances in experimental medicine and biology · 2021
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Gas Signaling Molecules and Mitochondrial Potassium Channels.International journal of molecular sciences · 2018
    Review
  16. Review
  17. Biological signaling by small inorganic molecules.Coordination chemistry reviews · 2016
    Article
  18. Spa therapy: can be a valid option for treating knee osteoarthritis?International journal of biometeorology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

B KloeschLudwig Boltzmann Institute for Rheumatology and Balneology, Kurbadstrasse 14, 1100 Vienna, Austria. burkhard.kloesch@gmx.at
M Liszt
G Steiner
J Bröll
Ludwig Boltzmann Institute for Digital Health and PreventionVienna General Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitogen-activated protein kinases (MAPKs) play a central role in inflammatory processes, and their blockage represents pharmacological approaches in the treatment of autoimmune diseases like rheumatoid arthritis (RA). Alternatively, H(2)S has long been used in sulphur bath therapy for patients suffering from different types of rheumatic disorders, but reports about the beneficial effects of this form of therapy are controversial, rare and of poor scientific quality. The human chondrocyte cell line C-28/I2 was treated with two different MAPK inhibitors (SB203580 and U0126) or with various concentrations of the H(2)S donor Natrium hydrogen sulphide (NaHS). Thereafter, the secretion of IL-6 and IL-8 was quantified by enzyme-linked immunosorbent assays (ELISAs). The impact of NaHS on the regulation of p38 and ERK1/2 MAPK was confirmed by Western blot experiments. Furthermore, IL-6 and IL-8 expression was quantified by real-time polymerase chain reaction (RT-PCR) and ELISAs from cells which were exposed to SB203580, U0126 and NaHS and stimulated by IL-1β. The C-28/I2 cells constitutively expressed large quantities of IL-6 and IL-8. The data provided prove that in these cells, constitutive as well as IL-1β-induced IL-6 and IL-8 expression was partially and transiently blocked by the treatment of cells with both MAPK inhibitors and NaHS. Presented data seem to be important in evaluating the beneficial functions of MAPK inhibitors and H(2)S in immune-pathophysiological processes.

Indexed as

ButadienesCell LineChondrocytesDrug AntagonismEnzyme InhibitorsGene ExpressionHumansHydrogen SulfideImidazolesInterleukin-1betaInterleukin-6Interleukin-8Nitrilesp38 Mitogen-Activated Protein KinasesPyridinesButadienesEnzyme InhibitorsHydrogen SulfideImidazolesInterleukin-1betaInterleukin-6Interleukin-8Nitrilesp38 Mitogen-Activated Protein KinasesPyridinesSB 203580U 0126

Identifiers

PMID21161531
OpenAlexW1973927461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.